BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38361664)

  • 1. Association of vaginal oestradiol and the rate of breast cancer in Denmark: registry based, case-control study, nested in a nationwide cohort.
    Meaidi A; Pourhadi N; Løkkegaard EC; Torp-Pedersen C; Mørch LS
    BMJ Med; 2024; 3(1):e000753. PubMed ID: 38361664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system tumours among users of vaginal oestradiol tablets: A nationwide population-based study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    Eur J Neurol; 2023 Sep; 30(9):2811-2820. PubMed ID: 37309803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
    Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
    Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.
    Cuzick J; Chu K; Keevil B; Brentnall AR; Howell A; Zdenkowski N; Bonanni B; Loibl S; Holli K; Evans DG; Cummings S; Dowsett M
    Lancet Oncol; 2024 Jan; 25(1):108-116. PubMed ID: 38070530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ARTs on oncological outcomes in young breast cancer survivors.
    Condorelli M; De Vos M; Lie Fong S; Autin C; Delvigne A; Vanden Meerschaut F; Wyns C; Imbert R; Cheruy C; Bouziotis J; de Azambuja E; Delbaere A; Lambertini M; Demeestere I
    Hum Reprod; 2021 Jan; 36(2):381-389. PubMed ID: 33289029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local oestrogen for vaginal atrophy in postmenopausal women.
    Lethaby A; Ayeleke RO; Roberts H
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic organ prolapse following hysterectomy on benign indication: a nationwide, nulliparous cohort study.
    Husby KR; Gradel KO; Klarskov N
    Am J Obstet Gynecol; 2022 Mar; 226(3):386.e1-386.e9. PubMed ID: 34688595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of breast cancer in relation to reproductive factors in Denmark.
    Ewertz M; Duffy SW
    Br J Cancer; 1988 Jul; 58(1):99-104. PubMed ID: 3166899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
    Folkestad L
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
    Akrivis Ch; Varras M; Thodos A; Hadjopoulos G; Bellou A; Antoniou N
    Clin Exp Obstet Gynecol; 2003; 30(4):229-34. PubMed ID: 14664420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.
    Lidegaard O; Nielsen LH; Skovlund CW; Løkkegaard E
    BMJ; 2012 May; 344():e2990. PubMed ID: 22577198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
    Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
    Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal estrogen and association with dementia: A nationwide population-based study.
    Pourhadi N; Mørch LS; Holm EA; Torp-Pedersen CT; Meaidi A
    Alzheimers Dement; 2022 Apr; 18(4):625-634. PubMed ID: 34322991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal hormone therapy and dementia: nationwide, nested case-control study.
    Pourhadi N; Mørch LS; Holm EA; Torp-Pedersen C; Meaidi A
    BMJ; 2023 Jun; 381():e072770. PubMed ID: 37380194
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.